Back

Relaxin as a novel biomarker of cardiac fibrosis and left ventricular diastolic parameters in end-stage heart failure

6 December 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Cardiomyopathies Other myocardial diseases EACVI Premium Access EuroEcho-Imaging 2017

About the speaker

Photo
Doctor Edit Gara

Semmelweis University, Budapest (Hungary)

9 More presentations in this session

Presentation thumbnail
Significance of cardiac magnetic resonance imaging after aborted sudden cardiac death in patients with normal coronary angiography
Doctor H. Vago (Budapest, HU)
Abstract
Presentation thumbnail
Cardiac MRI for a better identification of structural heart disease in patients with ventricular arrhythmia
Doctor E. Conte (Milan, IT)
Abstract Slides
Presentation thumbnail
Three-dimensional strain echocardiography, vascular ultrasound and cardiac biomarkers in early detection of cardiotoxicity in non-Hodgkin lymphoma patients
Doctor D. Mihalcea (Bucharest, RO)
Abstract
Presentation thumbnail
Ranolazine post-treatment reduces cardiotoxic effects due to Trastuzumab Emtansine: in vitro and in vivo study
Doctor N. Maurea (Naples, IT)
Abstract Slides
Presentation thumbnail
Echocardiographic guided screening for Fabry disease in a metropolitan area not already explored
Professor R. Citro (Campobasso, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Cardiomyopathies

The Event

Event poster

EuroEcho-Imaging 2017

6 December - 9 December 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources